Sven Crafoord

Articles in journals

• Dabrowska-Kloda, K. , Olafsdottir, E. , Stefanou, A. & Crafoord, S. (2024). DMEK Surgery at a Tertiary Hospital in Sweden. Results and Complication Risks. Clinical Ophthalmology, 18, 1841-1849.
• Carlsson, J. , Fricke, O. , Dahlberg, A. & Crafoord, S. (2022). Retinal surgery quality indicators for uncomplicated primary rhegmatogenous retinal detachment without a national registry. Acta Ophthalmologica, 100 (8), e1589-e1594.
• Barth, H. , Crafoord, S. & Ghosh, F. (2021). A New Retinal Detachment Treatment Model for Evaluation of Vitreous Tamponades. Current Eye Research, 46 (3), 373-379.
• Makdoumi, K. & Crafoord, S. (2020). A prospective long-term follow-up study of optic disc pit maculopathy treated with pars plana vitrectomy, drainage of subretinal fluid and peeling of internal limiting membrane. Acta Ophthalmologica, 98 (8), 822-827.
• Barth, H. , Crafoord, S. , Arnér, K. & Ghosh, F. (2019). Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model. Graefe's Archives for Clinical and Experimental Ophthalmology, 257 (4), 769-783.
• Makdoumi, K. , Nilsson, T. K. & Crafoord, S. (2017). Levels of beta-trace protein in optic disc pit with macular detachment. Acta Ophthalmologica, 95 (8), 815-819.
• Barth, H. , Crafoord, S. , Andréasson, S. & Ghosh, F. (2016). A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute. Graefe's Archives for Clinical and Experimental Ophthalmology, 254 (4), 697-703.
• Barth, H. , Crafoord, S. W. , Arner, K. & Ghosh, F. K. (2016). Cellular CD68 and CD45r0 positive inflammatory responses of vitrectomy with vitreous substitutes. Investigative Ophthalmology and Visual Science, 57 (12).
• Barth, H. , Crafoord, S. , O'Shea, T. M. , Pritchard, C. D. , Langer, R. & Ghosh, F. (2014). A new model for in vitro testing of vitreous substitute candidates. Graefe's Archives for Clinical and Experimental Ophthalmology, 252 (10), 1581-1592.
• Bäckman, A. , Makdoumi, K. , Mortensen, J. & Crafoord, S. (2014). The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light. Acta Ophthalmologica, 92 (7), 656-661.
• Makdoumi, K. , Bäckman, A. , Mortensen, J. , Magnuson, A. & Crafoord, S. (2013). Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba Castellanii. Graefe's Archives for Clinical and Experimental Ophthalmology, 251 (2), 509-514.
• Makdoumi, K. , Mortensen, J. & Crafoord, S. (2013). Response to: evaluation of combined riboflavin and ultraviolet A as an alternative treatment for keratitis. Graefe's Archives for Clinical and Experimental Ophthalmology, 251 (3), 997-998.
• Slidsborg, C. , Lyng Forman, J. , Fielder, A. R. , Crafoord, S. , Baggesen, K. , Bangsgaard, R. , Callo Fledelius, H. , Greisen, G. & et al. (2012). Experts do not agree when to treat retinopathy of prematurity based on plus disease. British Journal of Ophthalmology, 96 (4), 549-553.
• Makdoumi, K. , Mortensen, J. , Sorkhabi, O. , Malmvall, B. & Crafoord, S. (2012). UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefe's Archives for Clinical and Experimental Ophthalmology, 250 (1), 95-102.
• Pritchard, C. D. , Crafoord, S. , Andréasson, S. , Arnér, K. M. , O'Shea, T. M. , Langer, R. & Ghosh, F. K. (2011). Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits. Acta Biomaterialia, 7 (3), 936-943.
• Crafoord, S. , Andreasson, S. & Ghosh, F. (2011). Experimental vitreous tamponade using polyalkylimide hydrogel. Graefe's Archives for Clinical and Experimental Ophthalmology, 249 (8), 1167-74.
• Joussen, A. M. , Rizzo, S. , Kirchhof, B. , Schrage, N. , Li, X. , Lente, C. , Hilgers, R. & Crafoord, S. (2011). Heavy silicone oil versus standard silicone oil in as vitreous tamponade in inferior PVR (HSO Study): interim analysis. Acta Ophthalmologica, 89 (6), e483-e489.
• Schulz-Key, S. , Carlsson, J. & Crafoord, S. (2011). Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction.. Acta Ophthalmologica, 89 (2), 159-165.
• Makdoumi, K. & Crafoord, S. (2011). Vasoproliferative retinal tumours in a Swedish population. Acta Ophthalmologica, 89 (1), 91-94.
• Landström, F. J. , Nilsson, C. O. S. , Crafoord, S. , Reizenstein, J. A. , Adamsson, G. M. & Löfgren, L. A. (2010). Electroporation therapy of skin cancer in the head and neck area.. Dermatologic Surgery, 36 (8), 1245-50.
• Makdoumi, K. , Bäckman, A. , Mortensen, J. & Crafoord, S. (2010). Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefe's Archives for Clinical and Experimental Ophthalmology, 248 (2), 207-212.
• Makdoumi, K. , Mortensen, J. & Crafoord, S. (2010). Infectious keratitis treated with corneal crosslinking. Cornea, 29 (12), 1353-1358.
• Makdoumi, K. , Bäckman, A. & Crafoord, S. (2010). Response to: Bactericidal effect of photo-activated riboflavin using UVA. Graefe's Archives for Clinical and Experimental Ophthalmology, 248 (5), 757-758.
• Crafoord, S. (2008). Do vitreoretinal patients benefit from the use of small-gauge instruments?. Acta Ophthalmologica, 86 (2), 120-121.
• Crafoord, S. , Karlsson, N. & la Cour, M. (2008). Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmologica, 86 (2), 146-150.

Chapters in books

• Crafoord, S. , Ghosh, F. & Sebag, J. (2014). Vitreous biochemistry and artificial vitreous. In: Jerry Sebag MD, FACS, FRCOphth, FARVO, Vitreous: in Health and Disease (pp. 81-92). New York, USA: Springer.

Conference papers

• Barth, H. , Crafoord, S. & Ghosh, F. K. (2018). Developing a retinal detachment model for in vivo testing of vitreous substitutes with repeated pars plana vitrectomy. In:  Investigative Ophthalmology and Visual Science. Paper presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO 2018), Honolulu, Hawaii, USA, April 28 - May 3, 2018. Lippincott-Raven Publishers.